A special issue of
Diseases (ISSN 2079-9721).
Deadline for manuscript submissions: 31 December 2020.
Special Issue Information
Dear Colleagues,
Lipids are an incredibly diverse group of organic compounds that are
structurally and biochemically involved in many physiological and
cellular processes. They act as messengers in inflammation and immunity
and are crucial in apoptosis, autophagy, and cell division. Over the
last few decades, research has demonstrated that the role of lipids in
health and diseases is of major importance and requires further research
to advance therapeutics. The purpose of this Special Issue is to
present current research that tackles the role of lipids in disease
development and/or treatment. Current challenges to treat diseases such
as cancer, neurological diseases, and cardiovascular diseases involve
potent lipid mediators including eicosanoids and platelet-activating
factors or changes of cellular lipid compositions. With the advances in
‘omics’ technologies and research, there is potential to discover novel
lipid biomarkers and lipid mediators with pro-resolving effects, such as
resolvins and protectins, and design new treatments.
This Special Issue will provide an open access opportunity to publish
research work and review articles related to recent advances in
understanding the role of lipids in health and disease and will
hopefully present new molecular insights for developing potential
therapeutic treatments as well as better patient diagnostic and disease
prevention strategies.
Dr. Ronan Lordan
Dr. Ioannis Zabetakis
Guest Editors
